Join ICQ president, Mike Bogan, as he moderates an upcoming ISPE webinar featuring accomplished biopharma industry guest speakers who will discuss the latest updates to ISPE’s Baseline® approach to commissioning and qualification of facilities, utilities, and equipment regulated by the FDA.
ISPE Baseline Guide Volume 5 Second Edition: Adopting the New Paradigm
Date: February 18, 2021
Time: 12:00pm – 1:00pm ET
Discussions will include:
- Challenges in adopting the updated methodology
- How to manage change and encourage adoption
- How adoption can lead to more integrated qualification
- End-user testimonials
Michael Polansky is currently the Director of Corporate Quality at AstraZeneca, where he serves as the primary Quality liaison with Global Engineering in the development of Engineering standards and improved quality focus of Engineering processes. Mike has also held Quality and CQV roles at Sanofi Pasteur, Centocor (now Janssen), and GlaxoSmithKline over the past 23 years.
Deborah Wild is the President of DW BioPharma and was previously Chief of Staff/Head Global Cell and Gene Therapy Business Management for Catalent, Cell and Gene Therapy. Deborah has over 30 years’ experience leading Quality Assurance, Quality Control, Validation, Regulatory Affairs, and Manufacturing groups.
How to Attend
ISPE members and non-members can attend this informative webinar by registering here. Registration deadline is February 17, 2021 at 5:00pm ET.